Cabot Corporation (NYSE:CBT) Receives Average Recommendation of “Hold” from Analysts

Cabot Corporation (NYSE:CBT) has received a consensus recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $85.80.

CBT has been the subject of a number of recent research reports. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. UBS Group increased their price objective on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research report on Friday, May 8th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Mizuho boosted their target price on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th.

Cabot Stock Performance

NYSE:CBT opened at $89.04 on Friday. The company has a fifty day simple moving average of $86.76 and a two-hundred day simple moving average of $78.65. The company has a market cap of $4.60 billion, a price-to-earnings ratio of 16.83, a price-to-earnings-growth ratio of 11.78 and a beta of 0.83. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.30 million. During the same quarter last year, the business posted $1.90 EPS. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities analysts anticipate that Cabot will post 6.34 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is 35.73%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. UBS Group AG grew its holdings in shares of Cabot by 3.5% during the fourth quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock worth $40,708,000 after purchasing an additional 20,668 shares during the last quarter. Denali Advisors LLC purchased a new stake in shares of Cabot in the 4th quarter valued at about $5,531,000. Peregrine Capital Management LLC lifted its holdings in shares of Cabot by 24.7% in the 4th quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company’s stock valued at $5,246,000 after purchasing an additional 15,669 shares during the last quarter. Jefferies Financial Group Inc. boosted its position in shares of Cabot by 255.9% in the 4th quarter. Jefferies Financial Group Inc. now owns 36,570 shares of the specialty chemicals company’s stock valued at $2,424,000 after purchasing an additional 26,294 shares during the period. Finally, Norges Bank purchased a new position in Cabot during the 4th quarter worth approximately $49,662,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.